Drawing for GLOBAL CREATIVE BIOSCIENCES LAST MILE INNOVATION

USPTO serial 86225663

GLOBAL CREATIVE BIOSCIENCES LAST MILE INNOVATION

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
NOBLE, ANNIE MELISSA
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with GLOBAL CREATIVE BIOSCIENCES LAST MILE INNOVATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Dodds

JOHN DODDS DODDS & ASSOCIATES1707 N ST NWWASHINGTON, DC 20036-2829UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Amino acids for laboratory or research use; Assays and reagents for use in genetic research; Assays for research purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Biological tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biological tissue, namely, SHED stem cells (stem cells from human exfoliated deciduous teeth), dental pulp and human maxiofacial bone elements for scientific use and research in cellular healing therapies; Biological tissue, namely, cells for use in scientific and medical research; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Cell growth media for growing cells for use in scientific research; Cells for scientific, laboratory or medical research; Chemical preparations, namely, silica based density centrifugation media, to be used in biochemical and clinical research; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Chemical test kits for diseases and pests for laboratory or research use; Cryopreservation kits for use in scientific research consisting primarily of sperm freezing medium, in vitro fertilization medium, sperm freezing canister, cans for holding straws filled with semen, and mixing tubes; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic reagents for scientific or research use; Enzymes for scientific and research purposes; Fluorescent dye for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Protein arrays and nucleotide arrays for scientific and medical research; Protein in raw material form for scientific and medical research; Reagents for research purposes; Reagents for scientific or medical research use; Research reagents for industrial use, namely, for food testing; Stem cells for research or scientific purposes; Stem cells for research purposes; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 4, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 4, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 24, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2014DOCKASSIGNED TO EXAMINER—
Apr 3, 2014MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 2, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 22, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance